These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
324 related items for PubMed ID: 20001868
1. Dienogest: a new therapeutic agent for the treatment of endometriosis. Harada T, Taniguchi F. Womens Health (Lond); 2010 Jan; 6(1):27-35. PubMed ID: 20001868 [Abstract] [Full Text] [Related]
3. Pelvic pain and quality of life of women with endometriosis during quadriphasic estradiol valerate/dienogest oral contraceptive: a patient-preference prospective 24-week pilot study. Grandi G, Xholli A, Napolitano A, Palma F, Cagnacci A. Reprod Sci; 2015 May; 22(5):626-32. PubMed ID: 25394646 [Abstract] [Full Text] [Related]
4. Dienogest mediates midkine suppression in endometriosis. Nirgianakis K, Grandi G, McKinnon B, Bersinger N, Cagnacci A, Mueller M. Hum Reprod; 2016 Sep; 31(9):1981-6. PubMed ID: 27412246 [Abstract] [Full Text] [Related]
7. Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells. Ichioka M, Mita S, Shimizu Y, Imada K, Kiyono T, Bono Y, Kyo S. J Steroid Biochem Mol Biol; 2015 Mar; 147():103-10. PubMed ID: 25533385 [Abstract] [Full Text] [Related]
13. Dienogest was effective in treating hemorrhagic ascites caused by endometriosis: a case report. Asano R, Nakazawa T, Hirahara F, Sakakibara H. J Minim Invasive Gynecol; 2014 Mar; 21(6):1110-2. PubMed ID: 24780384 [Abstract] [Full Text] [Related]
14. Comparison of dienogest effects upon 3,3'-diindolylmethane supplementation in models of endometriosis and clinical cases. Morales-Prieto DM, Herrmann J, Osterwald H, Kochhar PS, Schleussner E, Markert UR, Oettel M. Reprod Biol; 2018 Sep; 18(3):252-258. PubMed ID: 30001982 [Abstract] [Full Text] [Related]
15. Risk factors for non-response and discontinuation of Dienogest in endometriosis patients: A cohort study. Nirgianakis K, Vaineau C, Agliati L, McKinnon B, Gasparri ML, Mueller MD. Acta Obstet Gynecol Scand; 2021 Jan; 100(1):30-40. PubMed ID: 32767677 [Abstract] [Full Text] [Related]
16. New treatment strategy for endometriosis using progestin-primed ovarian stimulation with dienogest: A prospective cohort study, comparison of dienogest versus dydrogesterone. Iwami N, Kawamata M, Ozawa N, Yamamoto T, Watanabe E, Mizuuchi M, Moriwaka O, Kamiya H. Reprod Biol; 2021 Mar; 21(1):100470. PubMed ID: 33333410 [Abstract] [Full Text] [Related]
17. Safety and Effectiveness of Dienogest (Visanne®) for Treatment of Endometriosis: A Large Prospective Cohort Study. Cho B, Roh JW, Park J, Jeong K, Kim TH, Kim YS, Kwon YS, Cho CH, Park SH, Kim SH. Reprod Sci; 2020 Mar; 27(3):905-915. PubMed ID: 32052358 [Abstract] [Full Text] [Related]
19. Clinical efficacy and safety of combined estradiol valerate and dienogest: a new no-bleed treatment. von Schoultz B. Climacteric; 2003 Aug; 6 Suppl 2():24-32. PubMed ID: 14669841 [Abstract] [Full Text] [Related]
20. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain. Kitawaki J, Kusuki I, Yamanaka K, Suganuma I. Eur J Obstet Gynecol Reprod Biol; 2011 Aug; 157(2):212-6. PubMed ID: 21474232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]